Comments
Venus Remedies , a research-oriented global pharmaceutical company, on Wednesday said it has bagged a patent from the US patent office for Achnil, a once-a-day painkiller injection developed by Venus Medicine Research Centre, its R&D arm. The patent will remain in force till 2032. The stock immediately reacted positively. After remaining in the red for most part of the day, it jumped 8.3 per cent to end at ₹231.95.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.